ANI Pharmaceuticals Inc
Uždarymo kaina
SektoriusSveikatos priežiūra
82.22 -0.36
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
82.04
Max
83.9
Pajamos | -61K 27M |
|---|---|
Pardavimai | -9.6M 237M |
P/E Sektoriaus vid. | 20.609 50.958 |
Pelnas, tenkantis vienai akcijai | 1.68 |
Pelno marža | 11.551 |
Darbuotojai | 970 |
EBITDA | -20M 57M |
Rekomendacijos | Stiprus pirkimas |
|---|---|
12 mėnesių prognozė | +37.81% upside |
Kitas uždarbis | 2026-08-07 |
|---|
Rinkos kapitalizacija | -41M 1.8B |
|---|---|
Ankstesnė atidarymo kaina | 82.58 |
Ankstesnė uždarymo kaina | 82.22 |
Naujienos nuotaikos
By Acuity
50%
50%
146 / 342 reitingas Healthcare
ANI Pharmaceuticals Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.